BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang T, Wu Y, Zhou H, Wu C, Zhang X, Chen Y, Zhao D. Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validation. BMC Gastroenterol 2021;21:38. [PMID: 33499821 DOI: 10.1186/s12876-021-01618-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wan M, Zhao D, Sun Y, Wang W, De Felice F. A Novel Overall Survival Nomogram Prediction of Secondary Primary Malignancies after Hypopharyngeal Cancer: A Population-Based Study. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/4681794] [Reference Citation Analysis]
2 Wang J, Shi L, Chen J, Wang B, Qi J, Chen G, Kang M, Zhang H, Jin X, Huang Y, Zhao Z, Chen J, Song B, Chen J. A novel risk score system for prognostic evaluation in adenocarcinoma of the oesophagogastric junction: a large population study from the SEER database and our center. BMC Cancer 2021;21:806. [PMID: 34256714 DOI: 10.1186/s12885-021-08558-1] [Reference Citation Analysis]
3 Zhou X, Chen H, Li S, Hua J, Zhang W, Li X, Si X, Zhang G. Treatment Options for T1 Stage Adenocarcinoma of Esophagogastric Junction: A Real-World Retrospective Cohort Study. Cancer Control 2021;28:10732748211063955. [PMID: 34913741 DOI: 10.1177/10732748211063955] [Reference Citation Analysis]